AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Director's Dealing 2018

Oct 23, 2018

Director's Dealing

Opens in your device viewer

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 22. October 2018) Rolf E. Engstad, CSO of Biotec BetaGlucans

has purchased 20 000 shares in Biotec Pharmacon at NOK 4.42 per share. After

this transaction holds Engstad 450.774 shares and 40.000 options in Biotec

Pharmacon

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187